Navidea Biopharmaceuticals (OTC:NAVBQ) has introduced that it filed a voluntary petition for reduction beneath Chapter 11, Subchapter V of the U.S. Chapter Code.
The submitting was made on October 1, 2025, within the U.S. Chapter Courtroom for the District of Delaware.
The corporate said that Chapter 11 submitting is meant to permit for an orderly restructuring of its monetary obligations whereas sustaining restricted operations to protect worth for its collectors and stakeholders.
Navidea plans to make use of the chapter course of to actively consider strategic alternate options, shield its core property, and guarantee equitable therapy for its collectors.
